A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL
Clinical trial NCT02972840 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02972840
- Sponsor
- Acerta Pharma BV
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-05
- Primary completion
- 2027-02-15
- Enrollment
- 635
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.